| Code | 00394 | ||||||||||
| MA number | 53/0762/92-S | ||||||||||
| Product Form: | sol inj 10x1 ml/1 mg | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | BB Pharma a.s., Czechia | ||||||||||
| Therapeutic Class: | 53 - PARASYMPATHOLYTICA, GANGLIOPLEGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass ampoule | ||||||||||
| Route of admin.: | Subcutaneous, intramuscular and intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 14.12.1992 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_ATROPIN BBP_sol inj_11_2019.doc
|
| PIL: |
PIL_ATROPIN BBP_sol inj_05_2023.pdf
|
| Safety feature | Yes |
| Data update: | 11.11.2019 |
